Alkermes Investor Presentation Deck
June 2023, 56 slides
  1. Alkermes
  2. Related Decks
  3. Investor Presentation Decks
executing on our strategy to drive shareholder value | Alkermes
forward looking statements and non financial information | Alkermes
table of contents | Alkermes
executive summary transformation has delivered significant value | Alkermes
executive summary transformation has delivered significant value | Alkermes
alkermes at a glance | Alkermes
alkermes at a glance | Alkermes
established three strategic priorities to drive shareholder value | Alkermes
executing on our strategic priorities to drive value creation | Alkermes
execution of our strategy has yielded significant results | Alkermes
strong stock price performance through the unaffected date date | Alkermes
also since the unaffected date date | Alkermes
significant expansion of alkermes valuation multiple over the last three years | Alkermes
analysts agree optimism around alkermes progress prospects | Alkermes
refreshed of independent directors since | Alkermes
driving value creation through years of strategic and governance change | Alkermes
developed attractive commercial portfolio | Alkermes
execution has yielded significant growth across our portfolio | Alkermes
exceeded expectations for launch highlights strong commercial execution and capabilities | Alkermes
increased proprietary revenue by in years | Alkermes
advanced pipeline to drive long term value creation | Alkermes
streamlined operations improved efficiencies across the company | Alkermes
commitment to profitability targets guides strategic decisions | Alkermes
overcoming obstacles to profitability through direct and decisive action a case study in the partial license termination | Alkermes
separating the alkermes oncology business expected to yield value for shareholders | Alkermes
separating the alkermes oncology business expected to yield value for shareholders | Alkermes
our commitment to board refreshment and strong corporate governance | Alkermes
qualified board driving growth profitability and value creation | Alkermes
appointed four directors with shareholder support | Alkermes
board focused on risk oversight | Alkermes
transformed corporate governance | Alkermes
responded to shareholders and improved compensation program | Alkermes
our experience with and our views on the nominees | Alkermes
record of effectively collaborating with shareholders on value enhancement | Alkermes
good faith engagement with despite their lack of additive plans or proposals | Alkermes
thorough review of candidates by alkermes board | Alkermes
two employees and nominee add no new value to the board | Alkermes
allegations of breach of fiduciary duty against raise issues of judgment and time commitment | Alkermes
and thoughtful refreshment has resulted in a board highly qualified to oversee the company | Alkermes
pops and are well positioned to oversee the company strategy | Alkermes
transformation has delivered significant value | Alkermes
transformation has delivered significant value | Alkermes
board vote recommendation | Alkermes
appendix | Alkermes
detail | Alkermes
dysfunction well defined opportunity in narcolepsy and other sleep disorders | Alkermes
leveraging alkermes molecular design capabilities to target dysfunction | Alkermes
additional governance information | Alkermes
leading commitment to and corporate responsibility | Alkermes
executive compensation programs designed to align incentives with shareholder interests | Alkermes
supplemental financial information | Alkermes
balance sheet as of march | Alkermes
quarterly financial results to non adjustments | Alkermes
annual financial results to non adjustments | Alkermes
financial expectations to non adjustments | Alkermes
alkermes | Alkermes
See More
Alkermes
Investor Presentation Decks
Drug Manufacturers—Specialty & Generic Decks
Healthcare Decks
Related Content
Articles:
Barbarians at the Gate
Explore Topics
Oncology
Skill
Recent decks by Alkermes
Investor Conference
January 2024
Results
October 2023
Investor Presentation
October 2023
Results
July 2023
See all presentations by Alkermes (22 decks)
Related decks
AstraZeneca
Investor Conference
January 2024
Genprex
Investor Presentation
October 2022
AbCellera
Results
February 2022
AstraZeneca
Results
February 2021
BioNTech
Results
November 2020
Invitae
Results
August 2023
Chimerix
Mergers and Acquisitions
January 2021
Relay Therapeutics
IPO
July 2020
Recent decks by Alkermes
See all presentations (22 decks)
Investor Conference
January 2024
Results
October 2023
Investor Presentation
October 2023
Results
July 2023
AstraZeneca
Investor Conference
January 2024
Genprex
Investor Presentation
October 2022
AbCellera
Results
February 2022
AstraZeneca
Results
February 2021
BioNTech
Results
November 2020
Invitae
Results
August 2023
Chimerix
Mergers and Acquisitions
January 2021
Relay Therapeutics
IPO
July 2020
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io